Sustained virological response (SVR) to peginterferon alfa-2a (40 KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) Vs induction therapy with interferon alfa-2a (roferon-A) plus RBV and AMA in IFN/RBV non responders (NR) with chronic hepatitis C

Authors
Publication date
1 January 2006
Publisher
CEPI

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    AIR Universita degli studi di Milano

    redirect
    oaioai:air.unimi.it:2434/32687
    Last time updated on 06/03/2019